Sitemap | Vector Labs

Posts

A New Focus for Breast Cancer: Protein Glycosylation’s Emerging Role (April 1, 2026)
Advancing Colorectal Cancer Research with Biomarker-Driven Tools (March 26, 2026)
Glycosylation in the Alzheimer’s Brain: Visualizing New Paths to Diagnosis and Therapy (March 19, 2026)
Meet Vector Labs at NextGen Omics 2026 (March 18, 2026)
Vector Laboratories’ Glysite Explorer Highly Commended for 2026 CiteAb Innovation Award (March 17, 2026)
Revisiting Colon Cancer Metastasis Through a Glycobiology Lens (March 5, 2026)
The Overlooked PTM: Making Glycosylation More Accessible to Researchers (February 18, 2026)
Quantum Dots (September 3, 2025)
Maleimide Crosslinker Selection Guide (September 1, 2025)
Vector Laboratories Launches Glysite™ Explorer in situ PLA Glycan Detection Kit to Advance Functional Proteomics Research (July 15, 2025)
A Career of Antibody Drug Conjugates (May 30, 2025)
Vector Laboratories and Spatomics Present Novel Method for Multiplexed Spatial Profiling of Glycans and Proteins at AACR (April 28, 2025)
Vector Laboratories Announces the Appointment of Ashley Scholz as Vice President of Marketing (February 24, 2025)
Vector Laboratories Announces Partnership With British Biotech Innovator Etcembly (February 20, 2025)
The art of the antibody curator (October 23, 2024)
Thinking on linkers for antibody-drug conjugates (September 6, 2024)
Growing Skills To Grow Your Company: 4 Lessons In Driving Successful Mergers And Acquisitions (August 13, 2024)
Dr. Lisa Sellers, CEO Vector Laboratories- Part 2 of 2 (August 13, 2024)
Vector Laboratories Merges With Absolute Biotech (May 24, 2024)
Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers (May 15, 2024)
Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers (May 14, 2024)
Authority Magazine. Operational Scalability: Kum Ming Woo of Vector Laboratories On How To Set Up Systems, Procedures, And People To Prepare A Business To Scale (April 1, 2024)
Podcast. Chartering a Path to the C-suite with Lisa Sellers, CEO, Vector Labs (March 23, 2024)
In Her Own Words: Vector Labs’ Lisa Sellers’ personal chemistry led to being CEO (March 20, 2024)
Strategizing Biotech Partnerships To Help Bring Therapies To Patients (March 15, 2024)
Bioanalysis Zone – Lisa Sellers talks opportunities, mentorship and initiatives for women in STEM (February 28, 2024)
Vector Laboratories, Navinci Diagnostics Partner to Develop Biomarker Discovery Tools (January 30, 2024)
Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery (January 30, 2024)
It Takes Two to Tango, Part 1: Bioconjugation (January 27, 2024)
It Takes Two to Tango, Part 2: Applications of Bioconjugation (January 27, 2024)
It Takes Two to Tango, Part 3: Advantages of Bioconjugation (January 27, 2024)
The right tool for the job: selecting appropriate protein detection and visualization methods (January 25, 2024)
Scrip Asks…What Does 2024 Hold For Biopharma? Part 2: The Funding Environment, M&A And Partnering (January 16, 2024)
SugarGPT: Envisioning the Future of Glycoinformatics (December 1, 2023)
The value and versatility of bioconjugation (November 1, 2023)
Adding efficiency and convenience to multiplexing workflows (September 6, 2023)
Glycans and B-cells: How glycans influence adaptive immunity (August 30, 2023)
Unleashing the power of secondary antibody applications (August 23, 2023)
Behind the Scenes: The Making of VectaPlex™ Antibody Removal Kit (August 16, 2023)
Moving From Command & Control to Coaching & Collaboration: Pamela James Of Vector Laboratories On How Leaders and Managers Can Become Better Coaches (August 13, 2023)
Ask the Scientist: Advancing Glycan Research for Personalized Medicine (August 11, 2023)
Immunostaining basics: What to know before starting (August 9, 2023)
How to use VectaPlex™ Antibody Removal Kit (August 2, 2023)
Putting people first for successful acquisition integration (July 27, 2023)
All about VECTASTAIN^® ABC Kits for immunodetection (July 26, 2023)
Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers (July 17, 2023)
Glycans and T-cells (July 12, 2023)
Glycosylation in cellular mechanisms of health and disease (June 28, 2023)
Breaking Barriers in STEM: Embracing Diversity and Cultivating Inclusive Spaces (June 21, 2023)
Investigating New Therapeutic Targets for Alzheimer’s Disease (June 7, 2023)
Glycans: Unleashing New Frontiers in Biomarker Discovery (May 31, 2023)
Supporting Women In STEM: How Companies Can Help Spark Early Interest (May 26, 2023)
The impact of STE(A)M mentorship: A glimpse from Newark Memorial High School’s visit to Vector Laboratories (May 17, 2023)
Lectin diversity: Where lectins come from (May 10, 2023)
Factors that Contribute to Huntington’s Disease Pathogenesis (May 3, 2023)
A Guide to Glycan-Binding Proteins (April 19, 2023)
A Guide to Understanding Lectins vs Antibodies (April 12, 2023)
In Search of an Early-stage Detection Test for Parkinson’s Disease (April 5, 2023)
Identifying cancer biomarkers with IHC/IF (March 29, 2023)
Immunotherapy and Glycans (March 15, 2023)
Glycans and the tumor microenvironment (March 8, 2023)
Leveraging Glycobiology for Biomarker Discovery (March 3, 2023)
Vector Laboratories Acquires Click Chemistry Tools and Fluoroprobes to Expand Manufacturing Capabilities (March 2, 2023)
The Role of Glycans in Colorectal Cancer Progression (March 1, 2023)
How to use lectins in glycobiology workflows (February 22, 2023)
Progress in Glycobiology: Building on Foundations and Continuing Momentum (February 20, 2023)
Mentoring for underrepresented students in STEM is important—let’s start with high school (February 18, 2023)
How to mount a coverslip on a slide (February 15, 2023)
2023 pharma predictions (February 9, 2023)
Considerations When Selecting a Primary Antibody (February 8, 2023)
Improving Functional Outcomes After Myocardial Infarction (February 1, 2023)
Everything We Know About Lectin Structure, Classification, and Function (January 25, 2023)
An Introduction to the Universe of Glycans (January 18, 2023)
Feeding curiosity, seeking balance, and making discoveries (January 4, 2023)
The Art Of Presenting (December 30, 2022)
2022: A year marked by a big move, traditions old and new, and prevailing teamwork (December 19, 2022)
Selecting a secondary antibody for Immunofluorescent staining (December 14, 2022)
Choosing secondary antibodies for IHC (December 7, 2022)
Visualizing the pathological intricacies of hearing loss (November 30, 2022)
Inspirational Women in STEM and Tech (November 27, 2022)
5 reasons to use the ImmEdge PAP Pen in your immunostaining workflow (November 16, 2022)
Answering your questions: How to detect glycan expression in tissue (November 9, 2022)
Alzheimer’s Awareness Month: What Makes Some Neurons More Vulnerable? (November 2, 2022)
On becoming a perspicacious neuroscientist (October 26, 2022)
My staining didn’t work, part 3: IHC and IF staining tips (October 19, 2022)
How labs and vendors can work together to improve reproducibility (October 14, 2022)
Glycobiology in Cancer Research and Applications (October 12, 2022)
My staining didn’t work, part 2: Absence of positive staining in IHC and IF (October 12, 2022)
My staining didn’t work, part 1: Background staining in IHC and IF (October 5, 2022)
Absolute Biotech Launches to Offer Antibody Reagents, Services and Expertise to Researchers Worldwide (October 4, 2022)
Breast Cancer Awareness Month: Impact of polysialylation in breast cancer outcomes (September 28, 2022)
Finding a niche in the pursuit of justice (September 21, 2022)
How to protect your tissue from photobleaching (September 14, 2022)
Leukemia and Lymphoma Awareness Month: Understanding blood cancers (September 7, 2022)
Hope for Spinal Muscular Atrophy through different research approaches (August 24, 2022)
From dermatology to biofilm and beyond (August 17, 2022)
Transforming A Mature Business: Evolving While Preserving An Established Reputation (August 15, 2022)
How to choose antifade mounting media (August 10, 2022)
A behind-the-scenes look at the development of Glysite Scout (August 3, 2022)
Is it time to relocate your company? Five lessons we learned in the process. (August 3, 2022)
Vector Laboratories earns prestigious ISO 9001:2015 certification of its new facility (August 2, 2022)
How to use Glysite Scout Glycan Screening Kits (July 27, 2022)
Vector Laboratories Expands Executive Team with Two New Hires (July 26, 2022)
The Importance of Lectin and Glycan Binding Specificity (July 20, 2022)
Vector Laboratories Launches Glysite™ Scout Glycan Screening Kits to Progress Glycobiology Research (July 19, 2022)
How glycobiology impacts cancer research (July 13, 2022)
Untangling the mysteries of brain development (July 6, 2022)
A time for celebration at Vector Laboratories (June 29, 2022)
Women of Influence 2022: Lisa Sellers of Vector Laboratories (June 25, 2022)
Immunohistochemistry Troubleshooting (June 21, 2022)
Company veteran: A day in the life of a research director at Vector Laboratories (June 15, 2022)
5 sources of non-specific staining and background in IHC and IF (June 8, 2022)
Alzheimer’s Awareness Month: The Impact of IL-17 Accumulation on Cognitive Deficit (June 1, 2022)
5 ways immunohistochemistry contributes to cancer research (May 25, 2022)
How glycobiology contributes to research (May 11, 2022)
How to prevent tissue and reagent loss on your slides (May 4, 2022)
Setting media vs non-setting mounting media: Which is right for you? (April 27, 2022)
5 ways lectins contribute to glycobiology (April 20, 2022)
Connecting the dots: a day in the life of a senior scientist at Vector Laboratories (April 13, 2022)
One-step, two-step, amplify: How to choose the right IHC detection system (April 6, 2022)
Glycobiology: The next frontier of cancer research (March 30, 2022)
Vector Laboratories Adds Kum Ming Woo to Executive Team as Vice President, Operations (March 29, 2022)
Honing Your Multiplex Immunohistochemistry Skills (March 23, 2022)
Following gut instincts and the intertwining pathways of sisterhood, part deux (March 16, 2022)
Embracing change. Evolving direction. Emboldened new look. (March 16, 2022)
Vector Laboratories Selects Newark, CA for New Corporate Headquarters (March 16, 2022)
Sea Lamprey in Glycobiology: Anti-Glycan Reagents from the depths of the Atlantic Ocean (March 8, 2022)
How to improve your immunofluorescence by overcoming autofluorescence (March 2, 2022)
Top Considerations for Selecting Immunohistochemistry (IHC) Detection Reagents (February 23, 2022)
Vector Laboratories Adds Katy Miles to its Board (February 22, 2022)
Establishing lifelong connections, building a new lab, and repurposing therapeutics (February 16, 2022)
Bioconjugation reveals new therapeutic possibilities for autoimmune disorders (February 9, 2022)
Improved Detection Strategies for Pancreatic Cancer: The Role of Imaging Mass Spectrometry and Lectin Analysis (February 2, 2022)
Start Right to Finish Well—The Importance of the Sample Preparation Process in Your IHC and IF Workflow (January 21, 2022)
Following gut instinct and the intertwining pathways of sisterhood (January 19, 2022)
Easy as Do-Re-Mi: Getting Started with Multiplex Immunohistochemistry (January 12, 2022)
Leveraging Lectins for Glycan Analysis (January 5, 2022)
Vector Laboratories: A look back at 2021 (December 22, 2021)
Our Top 10 Posts of 2021 Will Lend You a Helping Hand in the Lab (December 15, 2021)
Mike Morales Joins Vector Laboratories as Chief Financial Officer (December 14, 2021)
Answering Your Questions: Getting Started With Multiplex Immunohistochemistry (November 26, 2021)
A dissertation in hand, a job search in process, a scientific adventure commences (November 20, 2021)
Lectins 101: How Plant Lectins Can Accelerate Cancer Biomarker Discovery (November 10, 2021)
Following the developmental pathway to improved treatments (November 10, 2021)
Celebrating the art of scientific discovery (November 4, 2021)
What’s in a name? Glycans and sugars and lectins … Oh my! (November 3, 2021)
Women Of The C-Suite (October 31, 2021)
Reduce Tissue Autofluorescence and Dramatically Enhance Signal-to-Noise Ratio (October 27, 2021)
Simplifying Tissue Cross-Reactivity: Screening Humanized Antibodies in Human Tissue (October 20, 2021)
Vector Laboratories Elevates Pamela James to Vice President, Product on Executive Team (October 16, 2021)
Histology in a nutshell: process it, cut it, put it on a slide, and see what it reveals (October 13, 2021)
The Inhibitory Effect of Bisecting N-Acetylglucosamine on Breast Cancer (October 6, 2021)
Go Your Own Way: Vector Laboratories Completes $124 Million Buyout and Initiates Acquisition Strategy (October 1, 2021)
Unmasking Epitopes Using Antigen Retrieval for Formalin-Fixed Tissue Staining (September 29, 2021)
HOMER3: A Novel Biomarker in Muscle-Invasive Bladder Cancer (September 22, 2021)
Microglial Activation and Soluble TREM2 as a Potential Biomarker of Alzheimer’s Disease (September 15, 2021)
Vector Labs decouples from Maravai, popping up shop with private capital, new CEO on board (September 9, 2021)
Spontaneous reactions of the hydrazone (September 8, 2021)
Vector Laboratories Completes $124 Million Buyout; Initiates Acquisition Strategy; Appoints Former 10x Genomics and Maravai LifeSciences Exec as CEO; Launches VectaMount Express (September 7, 2021)
Let’s Cut to the Chase: Tips and Tricks to Get the Most Out of Your Sectioning (September 1, 2021)
Red Blood Cell Mannoses: Role in Sickle Cell Diseases and Malaria Resistance (August 25, 2021)
The End of the Line: Considerations for Mounting Media Selection (August 18, 2021)
When No One Opens the Door and the Pathway Is Convoluted, Creativity Rules (August 18, 2021)
The Waiting Game: A Search for a Streamlined IHC Protocol (August 11, 2021)
There’s a New Mountant in Town (July 30, 2021)
Bioconjugation and Its Use in Biomolecular Research (July 28, 2021)
The Sialylation Pathways in Pancreatic Cancer and Their Role in Tumor Microenvironment Differentiation (July 21, 2021)
Investigating Cross-Reactive Antibodies of SARS-CoV-2 with LIBRA-seq (July 14, 2021)
The Life of a Histotechnologist: One Thin Section (July 14, 2021)
Dial up the Contrast with Counterstaining (July 7, 2021)
Macrophage-derived Microparticles to Improve the Efficacy of Anti-PD-1 Antibodies in Tumors (June 30, 2021)
A Simple Guide to Immunohistochemistry Substrate Selection (June 30, 2021)
Getting to the Specifics: Blocking for Immunohistochemistry (June 23, 2021)
Prioritizing gene therapy to help families, including her own (June 16, 2021)
An Introduction to Bioconjugation: Answering Your Questions (June 9, 2021)
Reduce TissueBetter Immunofluorescence at the Speed of Light (June 2, 2021)
The Curious Case of the Staining that Went Wrong (May 26, 2021)
Scientist Spotlight: Shuying (Linda) Xu (May 7, 2021)
Improving IHC & IF Staining Results (May 6, 2021)
Scientist Spotlight: Selvakumar “Selva” Subbian, PhD (April 15, 2021)
Nordic-MUbio announces acquisition of anti-dsRNA monoclonal manufacturer SCICONS (April 13, 2021)
Scientist Spotlight - Carolyn Jones, PhD (January 6, 2021)
Scientist Spotlight - Andrea Jeffers Wellington, PhD (October 7, 2020)
Scientist Spotlight - Nathan Martin (September 2, 2020)
Scientist Spotlight - Natalie Chen (August 5, 2020)
Scientist Spotlight - Mark Jones, PhD (July 15, 2020)
Scientist Spotlight - Enrico Radaelli, DVM, PhD, DECVP (June 17, 2020)
Scientist Spotlight – Jennifer Kielczewski, MS, PhD (June 17, 2020)
Scientist Spotlight - Brian Cobb, PhD (February 12, 2020)
Scientist Spotlight - Estrella Lopez Gordo, PhD (February 12, 2020)
Scientist Spotlight - Lara Mahal, PhD (January 29, 2020)
Vector Laboratories Attains ISO 9001:2015 Certification (November 14, 2018)
New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications (September 11, 2018)
Vector Laboratories Introduces New Website With Enhanced Tools and Technical Content (June 12, 2018)
Exalpha Biologicals, Inc. Announces Acquisition of Leading Producer of Egg-Derived Antibodies Gallus Immunotech Inc. (June 6, 2018)
Vector Laboratories Announces IHC Video Training Series (March 22, 2018)
Vector Laboratories Introduces First Effective Reagent for Autofluorescence Quenching (November 13, 2017)
Vector Laboratories Publishes New Guide for Immunofluorescence (October 18, 2017)
Vector Laboratories Awards Exclusive Canadian Distributorship to MJSBioLynx (October 10, 2017)
Vector Laboratories Publishes New Immunohistochemistry Guide (September 18, 2017)
Vector Laboratories Names NeoBioscience Exclusive Distributor for China (September 16, 2017)
New Double-Staining Kit Streamlines Immunofluorescence Workflow (September 6, 2017)
New Polymer Kit Enables IHC Staining of Two Target Antigens in One Protocol (September 3, 2017)
New Plant-based Block Minimizes Background Signal for Immunohistochemistry and Immunofluorescence (September 5, 2016)
New Fluorescent Red Substrate Provides Increased Sensitivity for Tissue Research (June 15, 2016)
Maravai LifeSciences Acquires Vector Laboratories (April 5, 2016)
Nordic-MUbio Acquisition (July 13, 2015)

Pages

Categories

Authors